Announce Date | 08/07/2024 |
EPS Normalized Actual | $2.93 (Beat by $0.02) |
EPS GAAP Actual | $2.93 (Beat by $0.02) |
Revenue Actual | $2.15625B |
Revenue Surprise | Beat by $2156.25M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 10.42454 | 10.65 | 10.2716 | 10.85098 | 3 |
Dec 2027 | 16.1795 | 6.86 | 16.02276 | 16.32814 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.87 | 0.87 | 2.15625B | 7.71% | 2156.25M |
FQ4 2021 (Dec 2021) | 0.72 | 0.72 | 2.19398B | 12.02% | 2193.98M |
FQ3 2021 (Sep 2021) | 1.02 | 1.02 | 2.20234B | 12.92% | 2202.34M |
FQ2 2021 (Jun 2021) | 0.89 | 0.89 | 2.13744B | 21.78% | 2137.44M |
FQ1 2021 (Mar 2021) | 0.66 | 0.66 | 1.99001B | 4.34% | 1990.01M |
FQ4 2020 (Dec 2020) | 0.61 | 0.61 | 1.93019B | -2.98% | 1930.19M |
FQ3 2020 (Sep 2020) | 0.74 | 0.74 | 1.91782B | 42.33% | 1917.82M |
FQ2 2020 (Jun 2020) | 0.12 | 0.12 | 1.67195B | 44.07% | 1671.95M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 4.24 | -- | 4.1731 | 4.28682 | 9 |
FQ3 2027 (Jul 2027) | 3.74 | -- | 3.68099 | 3.7813 | 9 |
FQ2 2027 (Jun 2027) | 3.73 | -- | 3.70653 | 3.75291 | 9 |
FQ1 2027 (Mar 2027) | 3.23 | -- | 3.20967 | 3.24984 | 15 |
FQ4 2026 (Oct 2026) | 3.98214 | -- | 3.94893 | 4.01062 | 13 |
FQ3 2026 (Jul 2026) | 3.74944 | -- | 3.71817 | 3.77626 | 17 |
FQ2 2026 (Jun 2026) | 3.75081 | -- | 3.69129 | 3.82188 | 17 |
FQ1 2026 (Mar 2026) | 3.338 | -- | 3.28503 | 3.40125 | 8 |
FQ4 2025 (Oct 2025) | 3.52529 | -- | 3.49589 | 3.5505 | 9 |
FQ3 2025 (Sep 2025) | 3.53611 | -- | 3.47999 | 3.60311 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.9B | -- | 2.86B | 2.92B | 11 |
FQ3 2027 (Jul 2027) | 2.82B | -- | 2.79B | 2.85B | 8 |
FQ2 2027 (Jun 2027) | 2.81B | -- | 2.8B | 2.83B | 9 |
FQ1 2027 (Mar 2027) | 2.65B | -- | 2.64B | 2.66B | 9 |
FQ4 2026 (Oct 2026) | 2.7B | -- | 2.69B | 2.72B | 9 |
FQ3 2026 (Jul 2026) | 2.62B | -- | 2.6B | 2.63B | 10 |
FQ2 2026 (Jun 2026) | 2.56B | -- | 2.53B | 2.6B | 10 |
FQ1 2026 (Mar 2026) | 2.4B | -- | 2.38B | 2.44B | 16 |
FQ4 2025 (Oct 2025) | 2.56B | -- | 2.54B | 2.57B | 11 |
FQ3 2025 (Sep 2025) | 2.56B | -- | 2.53B | 2.6B | 11 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | 0.87 | 0.87 | 100% | |
FQ4 2021 (Dec 2021) | 0.72 | 0.72 | 100% | |
FQ3 2021 (Sep 2021) | 1.02 | 1.02 | 100% | |
FQ2 2021 (Jun 2021) | 0.89 | 0.89 | 100% | |
FQ1 2021 (Mar 2021) | 0.66 | 0.66 | 100% | |
FQ4 2020 (Dec 2020) | 0.61 | 0.61 | 100% | |
FQ3 2020 (Sep 2020) | 0.74 | 0.74 | 100% | |
FQ2 2020 (Jun 2020) | 0.12 | 0.12 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $2.16B | $2156.25M | 100% |
FQ4 2021 (Dec 2021) | $0B | $2.19B | $2193.98M | 100% |
FQ3 2021 (Sep 2021) | $0B | $2.2B | $2202.34M | 100% |
FQ2 2021 (Jun 2021) | $0B | $2.14B | $2137.44M | 100% |
FQ1 2021 (Mar 2021) | $0B | $1.99B | $1990.01M | 100% |
FQ4 2020 (Dec 2020) | $0B | $1.93B | $1930.19M | 100% |
FQ3 2020 (Sep 2020) | $0B | $1.92B | $1917.82M | 100% |
FQ2 2020 (Jun 2020) | $0B | $1.67B | $1671.95M | 100% |